TDP-43 based biomarker development in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis is a devastating neurodegenerative disease which is clinically and aetiologically heterogenous. However, TDP-43 neuropathology is a unifying hallmark found in 97% of ALS cases. Understanding the common pathological pathways downstream of TDP-43 dysregulation is essentia...
मुख्य लेखक: | Feneberg, E |
---|---|
अन्य लेखक: | Turner, M |
स्वरूप: | थीसिस |
भाषा: | English |
प्रकाशित: |
2019
|
विषय: |
समान संसाधन
-
Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis
द्वारा: Rachel H. Tan, और अन्य
प्रकाशित: (2023-11-01) -
Advancements in TDP-43 research: Towards biomarkers and therapeutic targets for amyotrophic lateral sclerosis
द्वारा: Yuhan Wu, और अन्य
प्रकाशित: (2025-03-01) -
The role of TDP-43 protein in amyotrophic lateral sclerosis
द्वारा: Piotr Włodarczyk, और अन्य
प्रकाशित: (2022-12-01) -
Kinesitherapy in amyotrophic lateral sclerosis
द्वारा: Joanna Iłżecka
प्रकाशित: (2017-12-01) -
Kinesitherapy in amyotrophic lateral sclerosis
द्वारा: Joanna Iłżecka
प्रकाशित: (2017-12-01)